Research and License Agreement [Abstract] Research and License Agreement [Text Block] Research and License Agreement [Text Block] The entire disclosure on research and license agreement entered by the entity. Consulting Agreements [Abstract] Consulting Agreements [Text Block] Consulting Agreements [Text Block] The entire disclosure for the consulting agreements with the consultants. Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Accounting Policies [Abstract] General And Going Concern [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Private Investors [Member] Class of Stock [Axis] Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Purchase Agreement [Member] Purchase agreement member. General And Going Concern [Line Items] Stockholders Equity, Reverse Stock Split Net Income (Loss) Attributable To Parent Net loss Net loss Net loss Stock Issued During Period, Value, New Issues Amount raised in Public offering Issuance of shares for public offering Research And License Agreement [Table] Income Statement Location [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Initial Research Period [Member] Extended Research Period [Member] Research And License Agreement [Line Items] Percentage Of Royalty PaymentIf Licensed Product Covered By Valid Claim Or Orphan Drug Status Percentage Of Royalty Payment If Licensed Product Covered By Valid Claim Or Orphan Drug Status This element represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is covered by a Valid Claim or is covered by Orphan Drug Status Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status This element represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is not covered by a Valid Claim or is not covered by Orphan Drug Status. Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status. Consulting Agreement [Table] Title of Individual [Axis] Deferred Bonus and Profit Sharing Plan by Title of Individual [Axis] Title Of Individual With Relationship To Entity [Domain] Title of Individual with Relationship to Entity [Domain] Eldad Melamed and Daniel Offen Consultants [Member] Prof Daniel Offen Consultant [Member] Prof.Daniel Offen Consultant [Member] Consultants [Member] Consulting Agreement [Line Items] Consulting Agreement Date Consulting Agreement Date The date on which consulting agreement is entered. Monthly Payment Of Consulting Fees Monthly Payment Of Consulting Fees Monthly payment of consulting fees paid. Monthly Payment Of Consulting Fees Cash Monthly Payment Of Consulting Fees, Cash Monthly payment of consulting fees in cash. Monthly Payment Of Consulting Fees Stock Monthly Payment Of Consulting Fees, Stock Monthly payment of consulting fees in stock, value. Research and Development Expense Research and Development Expense Research and development, net (Note 9) Research and Development Expense Stock Issued During Period, Shares, Issued For Services Stock Issued During Period, Shares, Issued for Services Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Number Amount of options, Outstanding at beginning of period Amount of options, Outstanding at end of period Options outstanding at end of period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross Amount of options, Granted Number of warrants issued Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period Amount of options, Exercised Exercised Exercise of options (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period Amount of options, Cancelled Forfeited Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Number Amount of options, Vested and expected-to-vest at end of period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Outstanding at beginning of period (in dollars per share) Weighted average exercise price, Outstanding at end of period (in dollars per share) Exercise price (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Grants In Period, Weighted Average Exercise Price Weighted average exercise price, Granted (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Exercise Price Weighted average exercise price, Exercised (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Exercise Price Weighted Average exercise Price, Cancelled (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Vested and expected-to-vest at end of period (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, Outstanding at end of period (in dollars) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value, Vested and expected-to-vest at end of period (in dollars) Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, At Carrying Value Cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at end of the period Short-term Investments Short-term deposit Nontrade Receivables, Current Account receivable (Note 5) Prepaid Expense, Current Prepaid expenses Assets, Current Total current assets Assets, Noncurrent [Abstract] Long-Term Assets: Prepaid Expense, Noncurrent Prepaid expenses Long-Term Investments Total long-term investments Property, Plant and Equipment, Net Property and Equipment, Net (Note 6) Depreciated cost Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Trade payables Accrued Liabilities, Current Accrued expenses Accounts Payable, Other, Current Other accounts payable Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-Term Liabilities: Warrants and Rights Outstanding Warrants issued to investors (Note 8(b)(1)(f)) Liabilities, Noncurrent, Total Total long-term liabilities Liabilities Total liabilities Stockholders Equity Attributable To Parent [Abstract] Stockholders' Equity: Common Stock, Value, Issued Stock capital: (Note 8) Common stock of $0.00005 par value - Authorized: 800,000,000 shares at December 31, 2014 and December 31, 2013; Issued and outstanding: 15,281,497 and 11,750,881 shares at December 31, 2014 and December 31, 2013 respectively. Additional Paid In Capital, Common Stock Additional paid-in-capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders Equity Attributable To Parent Total stockholders' equity Balance Balance Liabilities and Equity Total liabilities and stockholders' equity Equity Components [Axis] Statement, Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Warrant [Member] Vesting [Axis] Vesting [Domain] Issuance Date Nov - Dec 2004 [Member] Issuance Date Feb - Dec 2005 [Member] Issuance Date Feb - Dec 2006 [Member] Issuance Date Mar Nov 2007 [Member] Issuance Date Mar - Nov 2007 [Member] Issuance Date Nov 2008 [Member] Issuance Date Apr Nov 2008 [Member] Issuance Date Apr - Nov 2008 [Member] Issuance Date Apr - Oct 2009 [Member] Issuance Date Aug 2007 - Jan 2011 [Member] Issuance Date Jan 2010 [Member] Issuance Date Feb 2010 [Member] Issuance Date Feb 2010 One [Member] Issuance Date Feb 2010 Two [Member] Issuance Date Apr 2010 [Member] Issuance Date Jan 2011 [Member] Issuance Date Feb 2011 [Member] Issuance Date Feb 2011 One [Member] Issuance Date Feb 2011 Two [Member] Issuance Date Apr 2011 [Member] Issuance Date Apr 2012 [Member] Issuance Date July 2012 [Member] Issuance Date July 2012 One [Member] Issuance Date July 2012 Two [Member] Issuance Date Feb 2013 [Member] Issuance Date Apr 2010-2014 [Member] Issuance Date Aug 2013 [Member] Issuance Date Aug 2013 One [Member] Issuance Date June 2014 [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Maximum [Member] Class of Warrant or Right, Outstanding Outstanding Investment Warrants, Exercise Price Exercise Price (in dollars per share) Investment Warrants, Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Number Warrants Exercisable Options exercisable Warrant Exercisable Term Exercisable through Date the warrants or rights are exercisable, in CCYY-MM-DD format. Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Research and Development Expense [Member] Research and development [Member] General and Administrative Expense [Member] General and administrative [Member] Interest Expense [Member] Financial expenses, net [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation, Total Total stock-based compensation expense Subsidiary, Sale Of Stock [Axis] Subsidiary, Sale of Stock [Axis] Sale Of Stock, Name Of Transaction [Domain] Sale of Stock, Name of Transaction [Domain] Private Placement [Member] Public Offering [Member] Investors Private Placement [Member] Common Stock [Member] Warrant Issued One [Member] Warrant Issued One Member. Warrant Issued Two [Member] Warrant Issued Two Meber. Warrant Issued Three [Member] Unregistered Shares of Common Stock [Member] Related Party [Member] Related Party Member. Leader Underwriters1993 Ltd [Member] Leader Underwriters (1993) Ltd [Member] Leader Underwriters (1993) Ltd Member Investor [Member] Prof. Israeli and Hadasit [Member] Holders of Warrants [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Cash [Member] Option Indexed To Issuer'S Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Axis] Option Indexed To Issuer'S Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Global Share Option Plan2004 and U S Stock Option and Incentive Plan2005 [Member] Global Share Option Plan 2004 and U S Stock Option and Incentive Plan 2005 [Member] Global Share Option Plan 2004 [Member] Global Share Option Plan 2004 Member. U S Stock Option And Incentive Plan2005 [Member] U S Stock Option And Incentive Plan 2005 [Member] U S Stock Option and Incentive Plan [Member] Global Share Option Plan 2014 and U S Stock Option and Incentive Plan 2014 [Member] Director [Member] Employee [Member] Employee Member. Director One [Member] Director One Member. Director Two [Member] Director Two Member. Former Chief Executive Officer [Member] Former Chief Executive Officer Member. Hadasit [Member] Hadasit Member. Mr Israeli [Member] Mr. Israeli [Member] Mr Israeli Member. Chief Operating Officer [Member] Prof Melamed [Member] Former Director [Member] Former Director Member. Chief Executive Officer [Member] Former Chief Financial Officer [Member] Scientific Board [Member] Board [Member] Mr Schor [Member] Mr. Schor [Member] Management [Member] Investor One [Member] Investor Two [Member] Investor Three [Member] Chief Financial Officer [Member] Board Members One [Member] Board Members Two [Member] Member Of Gnc Committee [Member] Chairperson Of Gnc Committee [Member] U S Directors [Member] Director Three [Member] Director Four [Member] Restricted Stock [Member] Non Qualified Stock Option [Member] Stock Options One [Member] Enrollment Of One Third Of Patients [Member]